SAN FRANCISCO, CA, August 09, 2010 (Press-News.org) Lampire Biological Laboratories (LBL) announced today that it signed an agreement with Proliant Health and Biologicals (Proliant), manufacturer of the worlds most trusted, high quality Bovine Serum Albumin (BSA), to do contract filling & provide BSA to customers requiring less than Proliant's standard 10 kilogram packaging. Lampire will also offer made-to-order aqueous blends in buffers and package sizes to customer specifications.

Stephen Welch, President & CEO of Proliant, said, "Proliant has become the pre-eminent bulk manufacturer of BSA, currently supplying over half of global demand. As part of this rapid growth, Proliant is committed to supplying customers who require smaller quantities of BSA the same value large scale customers enjoy, plus a greater degree of flexibility and customer service." Stephen went on to say, "The search is now over; Lampire with its contract manufacturing abilities, plus an extensive knowledge of the diagnostic and pharmaceutical industries, fulfills every attribute Proliant requires."

According to Gregory F. Krug, President & CEO of LBL, "The applications for BSA are truly endless and we are proud to enter into this strategic partnership with Proliant." Greg went on to say, "...we are looking at drug development labs, academic research institutes, biotech companies and antibody suppliers all of which need high quality BSA. The Lampire Business Model will allow us to provide them with high quality BSA in a variety of forms and formulations in a most cost-effective manner."

About Lampire Biological Laboratories
Lampire Biological Laboratories specializes in polyclonal and monoclonal antibody development, cell culture devices and services, and a wide variety of blood-derived products. Founded in 1977, the Pennsylvania based company offers an extensive line of secondary antibodies, purified IgGs, human and animal blood products, plus a comprehensive line of animal tissues and organs. The latest product and service releases include novel teratogenicity screening assays, New Zealand sourced animal blood products, the gas-permeable LAMPIRE OMNI C3 Cell Culture Bag, exclusive antibodies to chemotherapeutic agents, and Proliant BSA. Additional services include peptide synthesis, antigen design, antibody purification, custom conjugation, immunoassay development, and contract manufacturing. Lampire is a privately held company.

About Proliant Health and Biologicals
Proliant, a privately held company, is the world's largest producer of bovine plasma derivatives, such as BSA. Derived from the plasma of healthy, US-origin animals with complete traceability, Proliant's bovine serum albumin exceeds 99% purity and is suitable for diagnostic, pharmaceutical, veterinary, and research applications.

Proliant Health and Biologicals specializes in the development of ingredients from natural sources for the human health and nutrition industry, including the dietary supplement, clinical nutrition, consumer health and functional food markets. Proliant has developed exciting new technologies to isolate bio-active proteins and peptides that play vital roles in human health. The most well-known of these are immunoglobulins.

Proliant ingredients are unsurpassed in innovation and quality, which allows them to be used in the most sensitive nutritional applications. ImmunoLin is an immunoglobulin protein isolate which can be used for tablets, capsules, drink mixes, lozenges and bars.

Contacts:

Lampire Biological Laboratories
Gregory F. Krug
President
Office: 215-795-2838
Website: http://www.proliantinc.com

or

Proliant Health & Biologicals
Jim Torvik
Director of Sales and Marketing
Office: 515-289-5142
Mobile: 515-494-0700